You are here

Strides Pharma to conduct trials in India for potential Covid-19 drug

rk_strides_210520.jpg
Indian pharmaceutical company Strides Pharma Science said on Thursday it has got regulatory approval to conduct clinical trials of antiviral drug favipiravir, considered a potential treatment for Covid-19.

[BENGALURU] Indian pharmaceutical company Strides Pharma Science said on Thursday it has got regulatory approval to conduct clinical trials of antiviral drug favipiravir, considered a potential treatment for Covid-19.

The Bengaluru-based company has received approval from the Drug...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes